Abstract
Glycosaminoglycans or GAGs are fundamental constituents of both cell surface and extracellular matrix (ECM), and through their localization they participate in many biological processes by playing a key role in cell-cell and cell-matrix interactions. Therefore, they present a great potential for the design and preparation of therapeutic drugs to treat major diseases such as ischemic heart disease, stroke, cancers, infectious diseases, and degenerative diseases. With the demand of both animal-free molecules and clean environmentally friendly processes, the production of GAG-mimetics or GAG-like molecules from other sources than mammalian tissues is flourishing. Glycans, carbohydrates, or polysaccharides from marine resources are unique in terms both of function and structure, and they differ considerably from those of terrestrial origin. With the simultaneous development of both glycoscience and marine biotechnologies, the potential of marine polysaccharides as an innovative source for new pharmaceuticals has emerged and gained considerable attention. Algal and microbial polysaccharides offer a tremendous structural diversity for drug discovery. With the recent progress in genetic engineering, the bacterial production of tailor-made polysaccharides will provide very competitive molecules with properties of interest especially to treat major diseases and to elaborate new applications in tissue engineering.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC (2012) Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng 18:806–815
Ale MT, Maruyama H, Tamauchi H, Mikkelsen JD, Meyer AS (2011) Fucoidan from Sargassum sp. and Fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo. Int J Biol Macromol 49:331–336
Al-Nahas MO, Darwish MM, Ali AE, Amin MA (2011) Characterization of an exopolysaccharide-producing marine bacterium, isolate Pseudoalteromonas sp AM. Afr J Microbiol Res 5:3823–3831
Alonso AA, Antelo LT, Otero-Muras I, Pérez-Gálvez R (2010) Contributing to fisheries sustainability by making the best possible use of their resources: the BEFAIR initiative. Trends Food Sci Technol 21:569–578
Arena A, Gugliandolo C, Stassi G, Pavone B, Iannello D, Bisignano G, Maugeri TL (2009) An exopolysaccharide produced by Geobacillus thermodenitrificans strain B3-72: antiviral activity on immunocompetent cells. Immunol Lett 123:132–137
Austin B (1989) Novel pharmaceutical compounds from marine bacteria. J Appl Bacteriol 67:461–470
Badri A, Williams A, Linhardt RJ, Koffas MAG (2018) The road to animal-free glycosaminoglycan production: current efforts and bottlenecks. Curr Opin Biotechnol 53:85–92
Bae S-Y, Yim JH, Lee HK, Pyo S (2006) Activation of murine peritoneal macrophages by sulfated exopolysaccharide from marine microalga Gyrodinium impudicum (strain KG03): involvement of the NF-[kappa]B and JNK pathway. Int Immunopharmacol 6:473–484
Barabanova A, Shashkov A, Glazunov V, Isakov V, Nebylovskaya T, Helbert W, Solov’eva T, Yermak I (2008) Structure and properties of carrageenan-like polysaccharide from the red alga Tichocarpus crinitus (Gmel.) Rupr. (Rhodophyta, Tichocarpaceae). J Appl Phycol 20:1013–1020
Barritault D, Gilbert-Sirieix M, Rice KL, Siñeriz F, Papy-Garcia D, Baudouin C, Desgranges P, Zakine G, Saffar J-L, van Neck J (2017) RGTA® or ReGeneraTing agents mimic heparan sulfate in regenerative medicine: from concept to curing patients. Glycoconj J 34:325–338
Berteau O, Mulloy B (2003) Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13:29R–40R
Bidarra SJ, Barrias CC, Granja PL (2014) Injectable alginate hydrogels for cell delivery in tissue engineering. Acta Biomater 10:1646–1662
Boisson-Vidal C, Zemani F, Caligiuri G, Galy-Fauroux I, Colliec-Jouault S, Helley D, Fischer AM (2007) Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae. Cardiovasc Hematol Agents Med Chem 5:67–77
Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB (1999) Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antivir Res 43:93–102
Casillo A, Lanzetta R, Parrilli M, Corsaro M (2018) Exopolysaccharides from marine and marine extremophilic bacteria: structures, properties, ecological roles and applications. Mar Drugs 16:69. https://doi.org/10.3390/md16020069
Chen RH, Chang JR, Shyur JS (1997) Effects of ultrasonic conditions and storage in acidic solutions on changes in molecular weight and polydispersity of treated chitosan. Carbohydr Res 299:287–294
Chen HM, Ouyang W, Martoni C, Afkhami F, Lawuyi B, Lim T, Prakash S (2010) Investigation of genipin cross-linked microcapsule for oral delivery of live bacterial cells and other biotherapeutics: preparation and in vitro analysis in simulated human gastrointestinal model. Int J Polym Sci 2010:1–10
Chen Y, Mao W, Tao H, Zhu W, Qi X, Chen Y, Li H, Zhao C, Yang Y, Hou Y, Wang C, Li N (2011) Structural characterization and antioxidant properties of an exopolysaccharide produced by the mangrove endophytic fungus Aspergillus sp. Y16. Bioresour Technol 102:8179–8184
Chen Y, Mao WJ, Yang YP, Teng XC, Zhu WM, Qi XH, Chen YL, Zhao CQ, Hou YJ, Wang CY, Li N (2012) Structure and antioxidant activity of an extracellular polysaccharide from coral-associated fungus, Aspergillus versicolor LCJ-5-4. Carbohydr Polym 87:218–226
Chen YL, Mao WJ, Tao HW, Zhu WM, Yan MX, Liu X, Guo TT, Guo T (2015) Preparation and characterization of a novel extracellular polysaccharide with antioxidant activity, from the mangrove-associated fungus Fusarium oxysporum. Mar Biotechnol 17:219–228
Chevolot L, Mulloy B, Ratiskol J, Foucault A, Colliec-Jouault S (2001) A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr Res 330:529–535
Church FC, Meade JB, Treanor RE, Whinna HC (1989) Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem 264:3618–3623
Ciancia M, Quintana I, Vizcarguenaga MI, Kasulin L, de Dios A, Estevez JM, Cerezo AS (2007) Polysaccharides from the green seaweeds Codium fragile and C. vermilara with controversial effects on hemostasis. Int J Biol Macromol 41:641–649
Colliec S, Fischer AM, Taponbretaudiere J, Boisson C, Durand P, Jozefonvicz J (1991) Anticoagulant properties of a fucoidan fraction. Thromb Res 64:143–154
Colliec S, Boisson-Vidal C, Jozefonvicz J (1994) A low molecular weight fucoidan fraction from the brown seaweed Pelvetia canaliculata. Phytochemistry 35:697–700
Colliec-Jouault S, Chevolot L, Helley D, Ratiskol J, Bros A, Sinquin C, Roger O, Fischer AM (2001) Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus. Biochim Biophys Acta 1528:141–151
Colliec-Jouault S, Millet J, Helley D, Sinquin C, Fischer AM (2003) Effect of low-molecular-weight fucoidan on experimental arterial thrombosis in the rabbit and rat. J Thromb Haemost 1:1114–1115
Colliec-Jouault S, Bavington C, Delbarre-Ladrat C (2012) Heparin-like entities from marine organisms. Handb Exp Pharmacol 207:423–449
Croisier F, Jérôme C (2013) Chitosan-based biomaterials for tissue engineering. Eur Polym J 49:780–792
Cumashi A, Ushakova NA, Preobrazhenskaya ME, D’Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE, Nazio CI (2007) A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17:541–552
Daniele MA, Boyd DA, Adams AA, Ligler FS (2015) Microfluidic strategies for design and assembly of microfibers and nanofibers with tissue engineering and regenerative medicine applications. Adv Healthc Mater 4:11–28
de Jesus Raposo MF, de Morais AMB, de Morais RMSC (2015) Marine polysaccharides from algae with potential biomedical applications. Mar Drugs 13:2967–3028
De Philippis R, Vincenzini M (1998) Exocellular polysaccharides from cyanobacteria and their possible applications. FEMS Microbiol Rev 22:151–175
DeAngelis PL (2012) Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl Microbiol Biotechnol 94:295–305
Deming J (1998) Deep ocean environmental biotechnology. Curr Opin Biotechnol 9:283–287
Deniaud-Bouet E, Hardouin K, Potin P, Kloareg B, Herve C (2017) A review about brown algal cell walls and fucose-containing sulfated polysaccharides: cell wall context, biomedical properties and key research challenges. Carbohydr Polym 175:395–408
Deux JF, Meddahi-Pelle A, Le Blanche AF, Feldman LJ, Colliec-Jouault S, Bree F, Boudghene F, Michel JB, Letourneur D (2002) Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler ThrombVasc Biol 22:1604–1609
Durand E, Helley D, Zen AAH, Dujols C, Bruneval P, Colliec-Jouault S, Fischer AM, Lafont A (2008) Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis. J Vasc Res 45:529–537
Fedorov SN, Ermakova SP, Zvyagintseva TN, Stonik VA (2013) Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects. Mar Drugs 11:4876–4901
Finore I, Di Donato P, Mastascusa V, Nicolaus B, Poli A (2014) Fermentation technologies for the optimization of marine microbial exopolysaccharide production. Mar Drugs 12:3005–3024
Foley SA, Szegezdi E, Mulloy B, Samali A, Tuohy MG (2011) An unfractionated fucoidan from ascophyllum nodosum: extraction, characterization, and apoptotic effects in vitro. J Nat Prod 74:1851–1861
Follin B, Juhl M, Cohen S, Pedersen AE, Gad M, Kastrup J, Ekblond A (2015) Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: phenotypic and immunomodulatory evaluation. Cytotherapy 17:1104–1118
Fonseca RJ, Oliveira SN, Melo FR, Pereira MG, Benevides NM, Mourao PA (2008) Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities. Thromb Haemost 99:539–545
Freeman I, Cohen S (2009) The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 30:2122–2131
Freitas F, Torres CAV, Reis MAM (2017) Engineering aspects of microbial exopolysaccharide production. Bioresour Technol 245:1674–1683
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455–482
Gardeva E, Toshkova R, Yossifova L, Minkova K, Gigova L (2012) Cytotoxic and apoptogenic potential of red microalgal polysaccharides. Biotechnol Biotechnol Equip 26:3167–3172
Geresh S, Mamontov A, Weinstein J (2002) Sulfation of extracellular polysaccharides of red microalgae: preparation, characterization and properties. J Biochem Biophys Methods 50:179–187
Han F, Yao W, Yang X, Liu X, Gao X (2005) Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP. Int J Biol Macromol 36:201–207
Hayakawa Y, Hayashi T, Lee JB, Ozawa T, Sakuragawa N (2000) Activation of heparin cofactor II by calcium spirulan. J Biol Chem 275:11379–11382
Hayashi K, Hayashi T, Kojima I (1996) A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Hum Retrovir 12:1463–1471
Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T (2008) Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immunopharmacol 8:109–116
Hemmingson JA, Falshaw R, Furneaux RH, Thompson K (2006) Structure and antiviral activity of the galactofucan sulfates extracted from Undaria Pinnatifida (Phaeophyta). J Appl Phycol 18:185–193
Heymann D, Ruiz-Velasco C, Chesneau J, Ratiskol J, Sinquin C, Colliec-Jouault S (2016) Anti-metastatic properties of a marine bacterial exopolysaccharide-based derivative designed to mimic glycosaminoglycans. Molecules 21:309. https://doi.org/10.3390/molecules21030309
Ikeda Y, Charef S, Ouidja M-O, Barbier-Chassefiere V, Sineriz F, Duchesnay A, Narasimprakash H, Martelly I, Kern P, Barritault D, Petit E, Papy-Garcia D (2011) Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosaccharides. Biomaterials 32:769–776
Imhoff JF, Labes A, Wieses J (2011) Bio-mining the microbial treasures of the ocean : new natural products. Biotechnol Adv 29:468–482
Jiao GL, Yu GL, Zhang JZ, Ewart HS (2011) Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar Drugs 9:196–223
Jin Z, Han YX, Han XR (2013) Degraded iota-carrageenan can induce apoptosis in human osteosarcoma cells via the Wnt/-Catenin signaling pathway. Nutr Cancer 65:126–131
Jurd KM, Rogers DJ, Blunden G, McLellan DS (1995) Anticoagulant properties of sulphated polysaccharides and a proteoglycan from Codium fragile ssp. atlanticum. J Appl Phycol 7:339–345
Kalitnik AA, Barabanova AOB, Nagorskaya VP, Reunov AV, Glazunov VP, Solov’eva TF, Yermak IM (2013) Low molecular weight derivatives of different carrageenan types and their antiviral activity. J Appl Phycol 25:65–72
Khil’chenko SR, Zaporozhets TS, Shevchenko NM, Zvyagintseva TN, Vogel U, Seeberger P, Lepenies B (2011) Immunostimulatory activity of fucoidan from the brown alga fucus evanescens: role of sulfates and acetates. J Carbohydr Chem 30:291–305
Khotimchenko YS (2010) The antitumor properties of nonstarch polysaccharides: carrageenans, alginates, and pectins. Russ J Mar Biol 36:401–412
Kim M, Yim JH, Kim SY, Kim HS, Lee WG, Kim SJ, Kang PS, Lee CK (2012) In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03. Antivir Res 93:253–259
Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65:173–179
Kralovec JA, Metera KL, Kumar JR, Watson LV, Girouard GS, Guan Y, Carr RI, Barrow CJ, Ewart HS (2007) Immunostimulatory principles from Chlorella pyrenoidosa – Part 1: isolation and biological assessment in vitro. Phytomedicine 14:57–64
Kuo CK, Ma PX (2001) Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 22:511–521
Kwak JY (2014) Fucoidan as a marine anticancer agent in preclinical development. Mar Drugs 12:851–870
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Laurienzo P (2010) Marine polysaccharides in pharmaceutical applications: an overview. Mar Drugs 8:2435–2465
Lee KY, Mooney DJ (2012) Alginate: properties and biomedical applications. Prog Polym Sci 37:106–126
Lee KY, Kong HJ, Larson RG, Mooney DJ (2003) Hydrogel formation via cell crosslinking. Adv Mater 15:1828–1832
Lee J-B, Hayashi K, Hirata M, Kuroda E, Suzuki E, Kubo Y, Hayashi T (2006) Antiviral sulfated polysaccharide from navicula directa, a diatom collected from deep-sea water in Toyama Bay. Biol Pharm Bull 29:2135–2139
Lee K, Silva EA, Mooney DJ (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8:153–170
Levy-Ontman O, Huleihel M, Hamias R, Wolak T, Paran E (2017) An anti-inflammatory effect of red microalga polysaccharides in coronary artery endothelial cells. Atherosclerosis 264:11–18
Liu RM, Bignon J, Haroun-Bouhedja F, Bittoun P, Vassy J, Fermandjian S, Wdzieczak-Bakala J, Boisson-Vidal C (2005) Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin. Anticancer Res 25:2129–2133
Luyt CE, Meddahi-Pelle A, Ho-Tin-Noe B, Colliec-Jouault S, Guezennec J, Louedec L, Prats HE, Jacob MP, Osborne-Pellegrin M, Letourneur D, Michel JB (2003) Low-molecular-weight fucoidan promotes therapeutic revascularization in a rat model of critical hindlimb ischemia. J Pharmacol Exp Ther 305:24–30
Martin M, Portetelle D, Michel G, Vandenbol M (2014) Microorganisms living on macroalgae: diversity, interactions, and biotechnological applications. Appl Microbiol Biotechnol 98:2917–2935
Martins A, Vieira H, Gaspar H, Santos S (2014) Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Mar Drugs 12:1066–1101
Matou S, Helley D, Chabut D, Bros A, Fischer A-M (2002) Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thromb Res 106:213–221
Matou S, Colliec-Jouault S, Galy-Fauroux I, Ratiskol J, Sinquin C, Guezennec J, Fischer A-M, Helley D (2005) Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro. Biochem Pharmacol 69:751–759
Matsuda M, Shigeta S, Okutani K (1999) Antiviral activities of marine Pseudomonas polysaccharides and their oversulfated derivatives. Mar Biotechnol 1:68–73
Mauray S, Sternberg C, Theveniaux J, Millet J, Sinquin C, Taponbretaudiere J, Fischer AM (1995) Venous antithrombotic and anticoagulant activities of a fucoidan fraction. Thromb Haemost 74:1280–1285
Mayer AMS, Rodriguez AD, Berlinck RGS, Fusetani N (2011) Marine pharmacology in 2007–2008: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol 153:191–222
Millet J, Jouault SC, Mauray S, Theveniaux J, Sternberg C, Boisson Vidal C, Fischer AM (1999) Antithrombotic and anticoagulant activities of a low molecular weight fucoidan by the subcutaneous route. J Thromb Haemost 81:391–395
Mishima T, Murata J, Toyoshima M, Fujii H, Nakajima M, Hayashi T, Kato T, Saiki I (1998) Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis 16:541–550
Miura Y, Fukuda T, Seto H, Hoshino Y (2016) Development of glycosaminoglycan mimetics using glycopolymers. Polym J 48:229–237
Mori N, Nakasone K, Tomimori K, Ishikawa C (2012) Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection. World J Gastroenterol 18:2225–2230
Moshaverinia A, Xu XT, Chen C, Akiyama K, Snead ML, Shi ST (2013) Dental mesenchymal stem cells encapsulated in an alginate hydrogel co-delivery microencapsulation system for cartilage regeneration. Acta Biomater 9:9343–9350
Moussavou G, Kwak DH, Obiang-Obonou BW, Maranguy CAO, Dinzouna-Boutamba SD, Lee DH, Pissibanganga OGM, Ko K, Seo JI, Choo YK (2014) Anticancer effects of different seaweeds on human colon and breast cancers. Mar Drugs 12:4898–4911
Murano E, Perin D, Khan R, Bergamin M (2011) Hyaluronan: from biomimetic to industrial business strategy. Nat Prod Commun 6:555–572
Muzzarelli RAA, Greco F, Busilacchi A, Sollazzo V, Gigante A (2012) Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: a review. Carbohydr Polym 89:723–739
Naderi-Meshkin H, Andreas K, Matin MM, Sittinger M, Bidkhori HR, Ahmadiankia N, Bahrami AR, Ringe J (2014) Chitosan-based injectable hydrogel as a promising in situ forming scaffold for cartilage tissue engineering. Cell Biol Int 38:72–84
Nakano K, Kim D, Jiang ZD, Ueno M, Okimura T, Yamaguchi K, Oda T (2012) Immunostimulatory activities of the sulfated polysaccharide ascophyllan from Ascophyllum nodosum in in vivo and in vitro systems. Biosci Biotechnol Biochem 76:1573–1576
Nandini CD, Itoh N, Sugahara K (2005) Novel 70-kDa chondroitin Sulfate/Dermatan sulfate hybrid chains with a unique heterogenous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J Biol Chem 280:4058–4069
Nardella A, Chaubet F, Boisson Vidal C, Blondin C, Durand P, Jozefonvicz J (1996) Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr Res 289:201–208
Nicolaus B, Kambourova M, Oner ET (2010) Exopolysaccharides from extremophiles: from fundamentals to biotechnology. Environ Technol 31:1145–1158
Nishino T, Nagumo T (1992) Anticoagulant and antithrombin activities of oversulfated fucans. Carbohydr Res 229:355–362
Nishino T, Aizu Y, Nagumo T (1991) The influence of sulfate content and molecular weight of a fucan sulfate from the brown seaweed Ecklonia kurome on its antithrombin activity. Thromb Res 64:723–731
Okami Y (1986) Marine microorganisms as a source of bioactive agents. Microb Ecol 12:65–78
Oreste P, Zoppetti G (2012) Semi-synthetic heparinoids. Handb Exp Pharmacol 207:403–422
Park H, Kang SW, Kim BS, Mooney DJ, Lee KY (2009) Shear-reversibly crosslinked alginate hydrogels for tissue engineering. Macromol Biosci 9:895–901
Pavao MSG (2014) Glycosaminoglycans analogs from marine invertebrates: structure, biological effects, and potential as new therapeutics. Front Cell Infect Microbiol 4:123. https://doi.org/10.3389/fcimb.2014.00123
Petit AC, Noiret N, Guezennec J, Gondrexon N, Colliec-Jouault S (2007) Ultrasonic depolymerization of an exopolysaccharide produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. Ultrason Sonochem 14:107–112
Pomin VH (2015) Marine non-glycosaminoglycan sulfated glycans as potential pharmaceuticals. Pharmaceuticals (Basel) 8:848–864
Praillet C, Grimaud JA, Lortat-Jacob H (1998a) Proteoglycans as therapeutic agents (I). M S-Med Sci 14:412–420
Praillet C, Lortat-Jacob H, Grimaud JA (1998b) Proteoglycans and pathology (ll). M S-Med Sci 14:421–428
Puvaneswary S, Raghavendran HB, Talebian S, Murali MR, Mahmod SA, Singh S, Kamarul T (2016) Incorporation of Fucoidan in β-Tricalcium phosphate-Chitosan scaffold prompts the differentiation of human bone marrow stromal cells into osteogenic lineage. Sci Rep-UK 6:24202. https://doi.org/10.1038/srep24202
Qi HM, Zhang QB, Zhao TT, Hu RG, Zhang K, Li Z (2006) In vitro antioxidant activity of acetylated and benzoylated derivatives of polysaccharide extracted from Ulva pertusa (Chlorophyta). Bioorg Med Chem Lett 16:2441–2445
Raja R, Hemaiswarya S, Kumar NA, Sridhar S, Rengasamy R (2008) A perspective on the biotechnological potential of microalgae. Crit Rev Microbiol 34:77–88
Ramirez F, Rifkin DB (2003) Cell signaling events: a view from the matrix. Matrix Biol 22:101–107
Raposo MFD, de Morais R, de Morais A (2013) Bioactivity and applications of sulphated polysaccharides from marine microalgae. Mar Drugs 11:233–252
Rechter S, Konig T, Auerochs S, Thulke S, Walter H, Dornenburg H, Walter C, Marschall M (2006) Antiviral activity of Arthrospira-derived spirulan-like substances. Antivir Res 72:197–206
Rederstorff E, Rethore G, Weiss P, Sourice S, Beck-Cormier S, Mathieu E, Maillasson M, Jacques Y, Colliec-Jouault S, Fellah BH, Guicheux J, Vinatier C (2017) Enriching a cellulose hydrogel with a biologically active marine exopolysaccharide for cell-based cartilage engineering. J Tissue Eng Regen Med 11:1152–1164
Re’em T, Tsur-Gang O, Cohen S (2010) The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGF beta 1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 31:6746–6755
Re’em T, Kaminer-Israeli Y, Ruvinov E, Cohen S (2012) Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials 33:751–761
Rehm BHA (2010) Bacterial polymers: biosynthesis, modifications and applications. Nat Rev Microbiol 8:578–592
Rioux LE, Turgeon SL, Beaulieu M (2009) Effect of season on the composition of bioactive polysaccharides from the brown seaweed Saccharina longicruris. Phytochemistry 70:1069–1075
Roger O, Kervarec N, Ratiskol J, Colliec-Jouault S, Chevolot L (2004) Structural studies of the main exopolysaccharide produced by the deep-sea bacterium Alteromonas infernus. Carbohydr Res 339:2371–2380
Rougeaux H, Kervarec N, Pichon R, Guezennec J (1999) Structure of the exopolysaccharide of Vibrio diabolicus isolated from a deep-sea hydrothermal vent. Carbohydr Res 322:40–45
Rowley JA, Madlambayan G, Mooney DJ (1999) Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45–53
Ruiz Velasco C, Baud’huin M, Sinquin C, Maillasson M, Heymann D, Colliec-Jouault S, Padrines M (2011) Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology. Glycobiology 21:781–795
Ruoslahti E, Yamaguchi Y (1991) Proteoglycans as modulators of growth factors activities. Cell 64:867–869
Saboural P, Chaubet F, Rouzet F, Al-Shoukr F, Ben Azzouna R, Bouchemal N, Picton L, Louedec L, Maire M, Rolland L, Potier G, Le Guludec D, Letourneur D, Chauvierre C (2014) Purification of a low molecular weight fucoidan for SPECT molecular imaging of myocardial infarction. Mar Drugs 12:4851–4867
Sadovskaya I, Souissi A, Souissi S, Grard T, Lencel P, Greene CM, Duin S, Dmitrenok PS, Chizhov AO, Shashkov AS, Usov AI (2014) Chemical structure and biological activity of a highly branched (1 -> 3,1 -> 6)-beta-D-glucan from Isochrysis galbana. Carbohydr Polym 111:139–148
Schaeffer DJ, Krylov VS (2000) Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol Environ Saf 45:208–227
Schmid J, Sieber V, Rehm B (2015) Bacterial exopolysaccharides: biosynthesis pathways and engineering strategies. Front Microbiol 6:496. https://doi.org/10.3389/fmicb.2015.00496
Schnabelrauch M, Scharnweber D, Schiller J (2013) Sulfated glycosaminoglycans as promising artificial extracellular matrix components to improve the regeneration of tissues. Curr Med Chem 20:2501–2523
Senni K, Pereira J, Gueniche F, Delbarre-Ladrat C, Sinquin C, Ratiskol J, Godeau G, Fischer A-M, Helley D, Colliec-Jouault S (2011) Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering. Mar Drugs 9:1664–1681
Senni K, Gueniche F, Changotade S, Septier D, Sinquin C, Ratiskol J, Lutomski D, Godeau G, Guezennec J, Colliec-Jouault S (2013) Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues. Mar Drugs 11:1351–1369
Seol YJ, Lee JY, Park YJ, Lee YM, Young K, Rhyu IC, Lee SJ, Han SB, Chung CP (2004) Chitosan sponges as tissue engineering scaffolds for bone formation. Biotechnol Lett 26:1037–1041
Shanmugam M, Mody KH (2000) Heparinoid-active sulphated polysaccharides from marine algae as potential blood anticoagulant agents. Curr Sci 79:1672–1683
Sheng J, Yu F, Xin Z, Zhao L, Zhu X, Hu Q (2007) Preparation, identification and their antitumor activities in vitro of polysaccharides from Chlorella pyrenoidosa. Food Chem 105:533–539
Shin S, Park JY, Lee JY, Park H, Park YD, Lee KB, Whang CM, Lee SH (2007) “On the fly” continuous generation of alginate fibers using a microfluidic device. Langmuir 23:9104–9108
Siddhanta AK, Shanmugam M, Mody KH, Goswami AM, Ramavat BK (1999) Sulphated polysaccharides of Codium dwarkense Boergs. from the west coast of India: chemical composition and blood anticoagulant activity. Int J Biol Macromol 26:151–154
Smit A (2004) Medicinal and pharmaceutical uses of seaweed natural products: a review. J Appl Phycol 16:245–262
Sogawa K, Yamada T, Sumida T, Hamakawa H, Kuwabara H, Matsuda M, Muramatsu Y, Kose H, Matsumoto K, Sasaki Y, Okutani K, Kondo K, Monden Y (2000) Induction of apoptosis and inhibition of DNA topoisomerase-I in K-562 cells by a marine microalgal polysaccharide. Life Sci 66:PL227–PL231
Sun JC, Tan HP (2013) Alginate-based biomaterials for regenerative medicine applications. Materials 6:1285–1309
Sun L, Wang L, Zhou Y (2012) Immunomodulation and antitumor activities of different-molecular-weight polysaccharides from Porphyridium cruentum. Carbohydr Polym 87:1206–1210
Sun LQ, Chu JL, Sun ZL, Chen LH (2016) Physicochemical properties, immunomodulation and antitumor activities of polysaccharide from Pavlova viridis. Life Sci 144:156–161
Tseng CK (2001) Algal biotechnology industries and research activities in China. J Appl Phycol 13:375–380
Ueno M, Cho K, Isaka S, Nishiguchi T, Yamaguchi K, Kim D, Oda T (2018) Inhibitory effect of sulphated polysaccharide porphyran (isolated from Porphyra yezoensis) on RANKL-induced differentiation of RAW264.7 cells into osteoclasts. Phytother Res 32:452–458
Ustyuzhanina NE, Bilan MI, Ushakova NA, Usov AI, Kiselevskiy MV, Nifantiev NE (2014) Fucoidans: pro- or antiangiogenic agents? Glycobiology 24:1265–1274
Vo T-S, Kim S-K (2010) Potential anti-HIV agents from marine resources: an overview. Mar Drugs 8:2871–2892
Wang J, Chen B, Rao X, Huang J, Li M (2007) Optimization of culturing conditions of Porphyridium cruentum using uniform design. World J Microbiol Biotechnol 23:1345–1350
Wang W, Wang S-X, Guan H-S (2012) The antiviral activities and mechanisms of marine polysaccharides: an overview. Mar Drugs 10:2795–2816
Wijesinghe W, Jeon YJ (2012) Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: a review. Carbohydr Polym 88:13–20
Yamada T, Ogamo A, Saito T, Watanabe J, Uchiyama H, Nakagawa Y (1997) Preparation and anti-HIV activity of low-molecular-weight carrageenans and their sulfated derivatives. Carbohydr Polym 32:51–55
Yang XB, Gao XD, Han F, Tan RX (2005a) Sulfation of a polysaccharide produced by a marine filamentous fungus Phoma herbarum YS4108 alters its antioxidant properties in vitro. Biochim Biophys Acta Gen Subj 1725:120–127
Yang XB, Gao XD, Han F, Xu BS, Song YC, Tan RX (2005b) Purification, characterization and enzymatic degradation of YCP, a polysaccharide from marine filamentous fungus Phoma herbarum YS4108. Biochimie 87:747–754
Yang J-S, Xie Y-J, He W (2011) Research progress on chemical modification of alginate: a review. Carbohydr Polym 84:33–39
Yim JH, Kim SJ, Ahn SH, Lee CK, Rhie KT, Lee HK (2004) Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03. Mar Biotechnol 6:17–25
Yim JH, Son E, Pyo S, Lee HK (2005) Novel sulfated polysaccharide derived from red-tide microalga Gyrodinium impudicum strain KG03 with immunostimulating activity in vivo. Mar Biotechnol 7:331–338
Yu G, Guan H, Ioanoviciu AS, Sikkander SA, Thanawiroon C, Tobacman JK, Toida T, Linhardt RJ (2002) Structural studies on kappa-carrageenan derived oligosaccharides. Carbohydr Res 337:433–440
Zanchetta P, Lagarde N, Guezennec J (2003) A new bone-healing material: a hyaluronic acid-like bacterial exopolysaccharide. Calcif Tissue Int 72:74–79
Zhang ZS, Zhang QB, Wang J, Song HF, Zhang H, Niu XZ (2010) Regioselective syntheses of sulfated porphyrans from porphyra haitanensis and their antioxidant and anticoagulant activities in vitro. Carbohydr Polym 79:1124–1129
Zhang ZY, Teruya K, Eto H, Shirahata S (2013) Induction of apoptosis by low-molecular-weight fucoidan through calcium- and caspase-dependent mitochondrial pathways in MDA-MB-231 breast cancer cells. Biosci Biotechnol Biochem 77:235–242
Zhou G, Sun Y, Xin H, Zhang Y, Li Z, Xu Z (2004) In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus. Pharmacol Res 50:47–53
Zuniga EA, Matsuhiro B, Mejias E (2006) Preparation of a low-molecular weight fraction by free radical depolymerization of the sulfated galactan from Schizymenia binderi (Gigartinales, Rhodophyta) and its anticoagulant activity. Carbohydr Polym 66:208–215
Zykwinska A, Marquis M, Sinquin C, Cuenot S, Colliec-Jouault S (2016) Assembly of HE800 exopolysaccharide produced by a deep-sea hydrothermal bacterium into microgels for protein delivery applications. Carbohydr Polym 142:213–221
Zykwinska A, Berre LT-L, Sinquin C, Ropartz D, Rogniaux H, Colliec-Jouault S, Delbarre-Ladrat C (2018) Enzymatic depolymerization of the GY785 exopolysaccharide produced by the deep-sea hydrothermal bacterium Alteromonas infernus: structural study and enzyme activity assessment. Carbohydr Polym 188:101–107
Acknowledgments
This work was supported by the CNRS in the framework of the GDR GAG (GDR 3739).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Colliec-Jouault, S., Zykwinska, A. (2019). Marine Glycosaminoglycans (GAGs) and GAG-Mimetics: Applications in Medicine and Tissue Engineering. In: Cohen, E., Merzendorfer, H. (eds) Extracellular Sugar-Based Biopolymers Matrices. Biologically-Inspired Systems, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-030-12919-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-12919-4_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12918-7
Online ISBN: 978-3-030-12919-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)